{
    "1": {
        "original": "what is the origin of COVID-19",
        "expanded": [
            "What are the geographical locations associated with the early reported cases of COVID-19?",
            "What are the scientific articles and research papers that discuss the possible sources of COVID-19 infection in humans?",
            "What is the timeline of confirmed cases and outbreaks of COVID-19 in various regions worldwide and their possible impact on global health?"
        ]
    },
    "2": {
        "original": "how does the coronavirus respond to changes in the weather",
        "expanded": [
            "** weather-related factors affecting SARS-CoV-2 transmission rates\n**",
            "** impact of holiday season travel on seasonal influenza vs. COVID-19 outbreaks\n**",
            "** changed extreme weather patterns potentially increasing/ decreasing COVID-19 viral activity"
        ]
    },
    "3": {
        "original": "will SARS-CoV2 infected people develop immunity? Is cross protection possible?",
        "expanded": [
            "Do individuals who have contracted SARS-CoV2 develop long-term immunity, and is there evidence of cross-protection against other coronaviruses?",
            "What is the likelihood of SARS-CoV2-infected individuals developing immunity to future infections, and are there any studies suggesting cross-protection against other coronaviruses?",
            "Can people who have been infected with SARS-CoV2 develop lasting immunity, and are there any findings indicating that this immunity may also provide protection against other coronaviruses?"
        ]
    },
    "4": {
        "original": "what causes death from Covid-19?",
        "expanded": [
            "What are the primary factors contributing to mortality in Covid-19 patients?",
            "What underlying conditions and immune system factors increase the risk of severe illness and death from Covid-19?",
            "What are the known predictors of high-risk mortality from Covid-19, including demographic, comorbidity, and treatment-related factors?"
        ]
    },
    "5": {
        "original": "what drugs have been active against SARS-CoV or SARS-CoV-2 in animal studies?",
        "expanded": [
            "identifying compounds proven effective in in vitro and/or in vivo experiments involving SARS-CoV and/or SARS-CoV-2 models in animals",
            "which compounds have demonstrated antiviral activity in preclinical studies against SARS-CoV or SARS-CoV-2 using animal models such as mice or rats",
            "list compounds with research evidence showing efficacy against SARS-CoV and/or SARS-CoV-2 in experimental animal studies conducted from 2020 to present"
        ]
    },
    "6": {
        "original": "what types of rapid testing for Covid-19 have been developed?",
        "expanded": [
            "What are the novel diagnostic methods for coronavirus rapid testing that have been created recently?",
            "What types of point-of-care COVID-19 testing have been developed with accelerated development processes?",
            "List the new COVID-19 testing strategies that utilize rapid diagnostic technologies and innovation."
        ]
    },
    "7": {
        "original": "are there serological tests that detect antibodies to coronavirus?",
        "expanded": [
            "Do serological tests exist that identify coronavirus-specific antibodies?",
            "What are the methods for diagnosing coronavirus infection through serum antibody analysis?",
            "Can laboratory tests detect coronavirus antibodies in blood samples to confirm past or present exposure?"
        ]
    },
    "8": {
        "original": "how has lack of testing availability led to underreporting of true incidence of Covid-19?",
        "expanded": [
            "What are the implications of restricted testing access on the reported cases of COVID-19, leading to potential underestimation of the disease's true prevalence?",
            "In what ways has the limited availability of diagnostic testing resources contributed to a disparity in reported COVID-19 cases, and how might this impact the understanding of the virus's transmission dynamics?",
            "How does the scarcity of testing opportunities for COVID-19 affect the accuracy of disease surveillance, and what are the subsequent consequences for public health interventions and decision-making?"
        ]
    },
    "9": {
        "original": "how has COVID-19 affected Canada",
        "expanded": [
            "What are the pandemic-related economic impacts on Canada?",
            "How has COVID-19 influenced public health policy and decision-making in Canada?",
            "What are the socio-demographic effects of the COVID-19 pandemic on Canadian communities?"
        ]
    },
    "10": {
        "original": "has social distancing had an impact on slowing the spread of COVID-19?",
        "expanded": [
            "How has physical separation of individuals affected the rate of COVID-19 transmission?",
            "What is the relationship between reduced human contact and the containment of the COVID-19 pandemic?",
            "Did the implementation of distancing measures lead to a significant reduction in the spread of COVID-19?"
        ]
    },
    "11": {
        "original": "what are the guidelines for triaging patients infected with coronavirus?",
        "expanded": [
            "Who should healthcare professionals prioritize when dealing with coronavirus patients in emergency situations?",
            "What are the clinical indicators for distinguishing between mild, moderate, and severe cases of coronavirus infection?",
            "What are the best practices for preventing the transmission of coronavirus among patients, healthcare workers, and family members?"
        ]
    },
    "12": {
        "original": "what are best practices in hospitals and at home in maintaining quarantine?",
        "expanded": [
            "How can individuals effectively isolate themselves at home and in healthcare settings to limit the spread of infectious diseases?",
            "What are the key protocols and guidelines healthcare professionals and individuals should follow to ensure proper quarantine procedures, particularly during outbreaks or pandemics?",
            "In which ways can quarantine strategies be optimized, considering factors such as personal hygiene, environmental disinfection, and social distancing, to minimize the risk of transmission in both clinical and domestic settings?"
        ]
    },
    "13": {
        "original": "what are the transmission routes of coronavirus?",
        "expanded": [
            "What channels or mechanisms allow the spread of coronavirus?",
            "How do viruses in the coronavirus family disseminate themselves among humans?",
            "What pathways enable the transmission of coronavirus to occur within a population?"
        ]
    },
    "14": {
        "original": "what evidence is there related to COVID-19 super spreaders",
        "expanded": [
            "Who are the individuals or groups identified as COVID-19 super spreaders, and what are the circumstances surrounding their transmission of the virus?",
            "What research studies or articles discuss the phenomenon of COVID-19 super spreaders, including the characteristics, behaviors, and environmental factors that contribute to their high transmission rates?",
            "Can you provide information on the measures taken by healthcare professionals, governments, and public health organizations to identify, track, and contain COVID-19 super spreaders, as well as the effectiveness of these efforts in reducing transmission rates and mitigating the spread of the virus?"
        ]
    },
    "15": {
        "original": "how long can the coronavirus live outside the body",
        "expanded": [
            "What is the survival time for COVID-19 viral particles in environmental conditions",
            "How long can SARS-CoV-2 remain infectious after exiting the human host",
            "What is the duration for which COVID-19 can persist in various surfaces and environments"
        ]
    },
    "16": {
        "original": "how long does coronavirus remain stable  on surfaces?",
        "expanded": [
            "what is the persistence time of sars-cov-2 on various surfaces?",
            "can coronavirus survive for extended periods on everyday surfaces?",
            "how long can corona viruses remain infectious on non-living materials?"
        ]
    },
    "17": {
        "original": "are there any clinical trials available for the coronavirus",
        "expanded": [
            "Is there a corpus of clinical trials related to SARS-CoV-2 or COVID-19?",
            "Can you retrieve COVID-19 clinical trials from biomedical literature or scientific publications?",
            "Are there any existing medical studies or trials involving the treatment or prevention of coronavirus infections?"
        ]
    },
    "18": {
        "original": "what are the best masks for preventing infection by Covid-19?",
        "expanded": [
            "What are the most effective types of face masks in preventing the spread of Covid-19 among healthcare workers in hospitals?",
            "What are the top mask-wearing practices for people with compromised immune systems to minimize the risk of Covid-19 transmission?",
            "What are the clinically-proven mask materials and designs that have demonstrated significant reduction in Covid-19 virus transmission during outbreaks in densely populated areas?"
        ]
    },
    "19": {
        "original": "what type of hand sanitizer is needed to destroy Covid-19?",
        "expanded": [
            "Effective hand sanitizer for COVID-19 transmission prevention",
            "Properties of hand sanitizer that inactivate SARS-CoV-2 virus",
            "Hand sanitizer formulations for COVID-19 risk reduction"
        ]
    },
    "20": {
        "original": "are patients taking Angiotensin-converting enzyme inhibitors (ACE) at increased risk for COVID-19?",
        "expanded": [
            "Do Angiotensin-converting enzyme inhibitors (ACE) increase susceptibility to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infections in patients?",
            "Is there a correlation between the use of Angiotensin-converting enzyme inhibitors (ACE) and the risk of COVID-19 severity, hospitalization, or death in patients?",
            "What is the impact of Angiotensin-converting enzyme inhibitors (ACE) treatment on the immune response to COVID-19 in patients, and are there any potential risks or side effects associated with this therapy?"
        ]
    },
    "21": {
        "original": "what are the mortality rates overall and in specific populations",
        "expanded": [
            "- What are the relevant population statistics related to mortality rates, including general demographic breakdowns such as age and gender?",
            "- What are the mortality rate distributions across specific socioeconomic and geographical areas, such as urban vs rural populations or low-income vs high-income zones?",
            "- Can you provide detailed mortality rate trends and comparisons across various age groups and chronic health conditions, with a focus on identifying high-risk populations and potential areas for targeted interventions?"
        ]
    },
    "22": {
        "original": "are cardiac complications likely in patients with COVID-19?",
        "expanded": [
            "What is the likelihood of cardiovascular events in individuals infected with SARS-CoV-2?",
            "Do patients with severe acute respiratory syndrome caused by COVID-19 have a higher risk of heart problems?",
            "What is the relationship between COVID-19 diagnosis and the occurrence of cardiac conditions such as myocardial infarction or heart failure?"
        ]
    },
    "23": {
        "original": "what kinds of complications related to COVID-19 are associated with hypertension?",
        "expanded": [
            "What are the reported associations between COVID-19 and hypertension, including comorbidities and disease outcomes?",
            "What is the current understanding of the impact of hypertension on COVID-19 severity, treatment, and mortality rates?",
            "What research has investigated the potential risks and consequences of hypertension for patients with COVID-19, including acute kidney injury, cardiac events, and respiratory failure?"
        ]
    },
    "24": {
        "original": "what kinds of complications related to COVID-19 are associated with diabetes",
        "expanded": [
            "Complications in patients with diabetes during the COVID-19 pandemic",
            "COVID-19 comorbidities and their occurrence in diabetic populations",
            "Association between diabetes comorbidities and symptoms/health outcomes of COVID-19 patients"
        ]
    },
    "25": {
        "original": "which biomarkers predict the severe clinical course of 2019-nCOV infection?",
        "expanded": [
            "Which biological markers are associated with a poor prognosis for individuals infected with the 2019-nCOV virus, indicating a high likelihood of severe clinical outcomes?",
            "Identify the genetic or molecular variables that are indicative of a severe clinical presentation in patients infected with the 2019-nCOV virus, and are therefore critical for predicting disease progression?",
            "What are the key lab markers or physiological indicators that can be used to forecast a worsening clinical trajectory in individuals with 2019-nCOV infection, allowing for early intervention and improved patient outcomes?"
        ]
    },
    "26": {
        "original": "what are the initial symptoms of Covid-19?",
        "expanded": [
            "Get documents describing common early warning signs of Covid-19 infection in human patients.",
            "Find information on initial manifestations of SARS-CoV-2 infection that typically occur in the human body.",
            "What are the key early indicators of Covid-19 disease onset reported by medical professionals and research studies?"
        ]
    },
    "27": {
        "original": "what is known about those infected with Covid-19 but are asymptomatic?",
        "expanded": [
            "Who are the individuals diagnosed with COVID-19 but show no symptoms, and what are the characteristics of their immune response?",
            "What do we know about the asymptomatic carriers of COVID-19 in terms of viral load, transmission, and potential onward spread?",
            "How do individuals who are infected with COVID-19 but remain asymptomatic differ from those who develop symptoms, and what are the implications for public health and epidemiology?"
        ]
    },
    "28": {
        "original": "what evidence is there for the value of hydroxychloroquine in treating Covid-19?",
        "expanded": [
            "Do any clinical trials indicate that hydroxychloroquine has therapeutic benefits for Covid-19 patients?",
            "What are the studies and research findings supporting the efficacy of hydroxychloroquine as a Covid-19 treatment option?",
            "Is there empirical evidence from real-world data and observational studies that hydroxychloroquine is an effective treatment for individuals infected with SARS-CoV-2?"
        ]
    },
    "29": {
        "original": "which SARS-CoV-2 proteins-human proteins interactions indicate potential for drug targets. Are there approved drugs that can be repurposed based on this information?",
        "expanded": [
            "Identify SARS-CoV-2 protein-ligand interactions with high similarity to human protein targets that are potentially druggable. Provide information on existing small molecule compounds that have shown efficacy in modulating these interactions.",
            "Find human proteins with known interactions that share structural and functional homology with SARS-CoV-2 proteins, indicating potential as repurposed drug targets for COVID-19 treatment. Analyze existing literature on these protein targets and their associated small molecule inhibitors.",
            "Discover novel SARS-CoV-2 protein-human protein interaction pairs with potential for therapeutic intervention. Identify existing FDA-approved drugs that have a similar chemical structure or mechanism of action to inhibitors binding to these interaction pairs, and discuss their feasibility as repurposed treatment options for COVID-19."
        ]
    },
    "30": {
        "original": "is remdesivir an effective treatment for COVID-19",
        "expanded": [
            "how well does remdesivir perform against COVID-19 in clinical trials",
            "what are the outcomes of patients who received remdesivir for COVID-19 treatment",
            "are there any studies that demonstrate the efficacy of remdesivir in treating severe or mild cases of COVID-19"
        ]
    },
    "31": {
        "original": "How does the coronavirus differ from seasonal flu?",
        "expanded": [
            "\"What are the distinct characteristics of coronaviruses compared to influenza viruses?\"",
            "\"Can you identify the key differences between the COVID-19 outbreak and other seasonal flu pandemics?\"",
            "\"What genetic features distinguish coronaviruses from other types of seasonal viruses, such as influenza?\""
        ]
    },
    "32": {
        "original": "Does SARS-CoV-2 have any subtypes, and if so what are they?",
        "expanded": [
            "What are the distinct variations of the SARS-CoV-2 virus found in literature?",
            "Can you list all documented classifications or genetic variations of SARS-CoV-2 identified by researchers so far?",
            "What are the known subgroups or genetically diverse strains of SARS-CoV-2 mentioned in scientific reports or studies?"
        ]
    },
    "33": {
        "original": "What vaccine candidates are being tested for Covid-19?",
        "expanded": [
            "Are there any vaccine candidates currently being evaluated for efficacy against Covid-19?",
            "What are the potential vaccine candidates in development to combat the Covid-19 pandemic?",
            "What vaccines are under investigation for use in treating Covid-19?"
        ]
    },
    "34": {
        "original": "What are the longer-term complications of those who recover from COVID-19?",
        "expanded": [
            "What are the known long-term health consequences for individuals who have contracted and survived COVID-19?",
            "What complications and conditions are typically observed in patients with a history of COVID-19 infection, particularly those who experienced severe symptoms or were hospitalized?",
            "What chronic health issues are more likely to develop in individuals who have recovered from COVID-19, and what are the key factors that contribute to the likelihood of these conditions?"
        ]
    },
    "35": {
        "original": "What new public datasets are available related to COVID-19?",
        "expanded": [
            "\"What datasets have been released to the public domain since 2020 that contain information on COVID-19?\"",
            "\"List open-source datasets portraying COVID-19 trends and statistics that I can access freely online.\"",
            "\"Find public repositories housing datasets related to COVID-19 research, encompassing demographic, clinical, and epidemiological data.\""
        ]
    },
    "36": {
        "original": "What is the protein structure of the SARS-CoV-2 spike?",
        "expanded": [
            "Structure and architecture of the SARS-CoV-2 spike protein",
            "Composition and conformation of the SARS-CoV-2 spike protein",
            "Description and representation of the SARS-CoV-2 spike protein at the atomic level"
        ]
    },
    "37": {
        "original": "What is the result of phylogenetic analysis of SARS-CoV-2 genome sequence?",
        "expanded": [
            "**\nPhylogenetic analysis of the SARS-CoV-2 genome sequence effects.",
            "**\nCoronaviruses, SARS-CoV-2, genetic relationship phylogenetic analysis.",
            "**\nComparative analysis, phylogenetic classification, SARS-CoV-2 virus genome."
        ]
    },
    "38": {
        "original": "What is the mechanism of inflammatory response and pathogenesis of COVID-19 cases?",
        "expanded": [
            "Find all documents related to immune response triggered by SARS-CoV-2 and its implications in COVID-19 disease progression.",
            "Identify documents discussing the molecular mechanisms underlying the inflammatory cascade in COVID-19 patients and the consequences of this process on human health.",
            "Retrieve documents discussing the pathophysiology of SARS-CoV-2 infection, with a focus on the interactions between the virus and host cells that lead to tissue damage and inflammatory response in COVID-19 patients."
        ]
    },
    "39": {
        "original": "What is the mechanism of cytokine storm syndrome on the COVID-19?",
        "expanded": [
            "What physiological responses in the body are associated with cytokine storm syndrome in COVID-19?",
            "What are the key immune system dysregulations that contribute to cytokine storm syndrome in the context of SARS-CoV-2 infection?",
            "How does an overactive immune response, specifically cytokine storming, influence the clinical manifestations and outcomes of COVID-19 in patients?"
        ]
    },
    "40": {
        "original": "What are the observed mutations in the SARS-CoV-2 genome and how often do the mutations occur?",
        "expanded": [
            "Identify mutations in the genetic code of SARS-CoV-2 and their frequency of occurrence in available genomic data.",
            "What mutations within the SARS-CoV-2 genome have been reported and quantified, with a specific focus on their epidemiological relevance and population prevalence.",
            "Extract information onvariations in the SARS-CoV-2 genome that have been experimentally confirmed and analyze the distribution and frequency of these mutations across different geographic locations and time points."
        ]
    },
    "41": {
        "original": "What are the impacts of COVID-19 among African-Americans that differ from the rest of the U.S. population?",
        "expanded": [
            "**Demographic disparities in COVID-19 impact: Focus on racial disparities**\nHow do the health outcomes and socioeconomic effects of COVID-19 differ among African-Americans compared to other racial groups in the U.S. population?",
            "**Geographic and ethnic specifics of COVID-19 vulnerability**\nWhat are the spatial and demographic factors that contribute to higher COVID-19 transmission rates and mortality among African-Americans in the United States, as compared to other racial and ethnic groups?",
            "**Associated social and economic variables influencing COVID-19 impact on African-Americans**\nWhat are the primary socioeconomic, healthcare access, and demographic factors that contribute to the disproportionate impact of COVID-19 on African-Americans compared to the rest of the U.S. population?"
        ]
    },
    "42": {
        "original": "Does Vitamin D impact COVID-19 prevention and treatment?",
        "expanded": [
            "What is the relationship between Vitamin D deficiency and the risk of severe COVID-19 illness?",
            "How does Vitamin D supplementation influence the immune system's response to SARS-CoV-2 infection?",
            "Are there any clinical studies examining the efficacy of Vitamin D as a potential adjunctive therapy for COVID-19 prevention or treatment?"
        ]
    },
    "43": {
        "original": "How has the COVID-19 pandemic impacted violence in society, including violent crimes?",
        "expanded": [
            "What is the relationship between the COVID-19 pandemic and rates of violent crime globally?",
            "How did the pandemic's disruptions affect domestic violence and intimate partner violence rates worldwide?",
            "What are the patterns and trends in reported violent crime incidents during the COVID-19 pandemic, and what can be inferred about their drivers and consequences?"
        ]
    },
    "44": {
        "original": "How much impact do masks have on preventing the spread of the COVID-19?",
        "expanded": [
            "What is the efficacy of face masks in curbing the propagation of COVID-19 viral transmission?",
            "How do masks contribute to reducing the transmission rates of SARS-CoV-2 virus?",
            "What is the role of facemask usage in mitigating the spread of COVID-19 infections among the general population?"
        ]
    },
    "45": {
        "original": "How has the COVID-19 pandemic impacted mental health?",
        "expanded": [
            "What are the psychological effects of the COVID-19 pandemic on individuals and communities worldwide?",
            "How have governments and healthcare systems responded to the mental health needs of populations during the COVID-19 crisis?",
            "What is the impact of social distancing measures, lockdowns, and remote work on the mental health of different demographic groups?"
        ]
    },
    "46": {
        "original": "what evidence is there for dexamethasone as a treatment for COVID-19?",
        "expanded": [
            "what are the studies demonstrating the efficacy of dexamethasone in treating covid-19 patients?",
            "do research findings support the use of dexamethasone as a treatment for severe covid-19 cases?",
            "identify relevant clinical trials or meta-analyses investigating dexamethasone as a therapeutic option for covid-19 patients"
        ]
    },
    "47": {
        "original": "what are the health outcomes for children who contract COVID-19?",
        "expanded": [
            "**Rephrased for different context**: How do COVID-19 infections affect pediatric health outcomes in relation to other childhood illnesses?",
            "**Focused on specific demographics**: What are the health outcomes for children under the age of 12 who contract COVID-19, and how do these outcomes differ from older children?",
            "**Considering multiple dimensions**: What are the correlations between COVID-19 infection severity, children's health outcomes, and the impact of long-term recovery in pediatric patients?"
        ]
    },
    "48": {
        "original": "what are the benefits and risks of re-opening schools in the midst of the COVID-19 pandemic?",
        "expanded": [
            "What are the health implications of reopening schools during the pandemic, and what are the potential consequences for students, teachers, and communities?",
            "What are the economic benefits and drawbacks of reopening schools in the US during the COVID-19 pandemic, and what are the trade-offs between reopening schools and other economic activities?",
            "How have different countries reopened schools during the pandemic, and what lessons can be learned from their experiences in terms of managing health risks and maintaining educational continuity?"
        ]
    },
    "49": {
        "original": "do individuals who recover from COVID-19 show sufficient immune response, including antibody levels and T-cell mediated immunity, to prevent re-infection?",
        "expanded": [
            "What is the immune response profile of individuals after recovery from COVID-19 in terms of antibody production and T-cell activity, and do these individuals exhibit long-term protection against re-infection?",
            "How do antibody levels and T-cell mediated immunity in individuals who have recovered from COVID-19 impact the likelihood of re-exposure to the virus, and do these individuals remain protected against severe illness or reinfection?",
            "What is the relationship between the magnitude and persistence of immune response, including antibody and T-cell responses, in individuals who have recovered from COVID-19, and can this protection prevent re-infection or mitigate disease severity upon re-exposure to the virus?"
        ]
    },
    "50": {
        "original": "what is known about an mRNA vaccine for the SARS-CoV-2 virus?",
        "expanded": [
            "What are the current developments and research advancements related to mRNA vaccine technology for SARS-CoV-2?",
            "How do mRNA-based vaccines compare to traditional vaccine approaches in terms of efficacy, safety, and production feasibility for the SARS-CoV-2 virus?",
            "What are the underlying molecular mechanisms and immune responses triggered by mRNA-based SARS-CoV-2 vaccines, and how do these compare to traditional vaccine platforms?"
        ]
    }
}